title: Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.
authors.forename: Björn
authors.initials: B
authors.lastname: Oqvist
authors.forename: Barry M
authors.initials: BM
authors.lastname: Brenner
authors.forename: João Paulo
authors.initials: JP
authors.lastname: Oliveira
authors.forename: Alberto
authors.initials: A
authors.lastname: Ortiz
authors.forename: Roland
authors.initials: R
authors.lastname: Schaefer
authors.forename: Einar
authors.initials: E
authors.lastname: Svarstad
authors.forename: Christoph
authors.initials: C
authors.lastname: Wanner
authors.forename: Kate
authors.initials: K
authors.lastname: Zhang
authors.forename: David G
authors.initials: DG
authors.lastname: Warnock
mesh_terms: D001706:Biopsy; D004252:DNA Mutational Analysis; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007527:Isoenzymes / Q000627:therapeutic use; D007674:Kidney Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D015997:Neonatal Screening; D010375:Pedigree; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D012307:Risk Factors; D013997:Time Factors; D014281:Trihexosylceramides / Q000652:urine; D000519:alpha-Galactosidase / Q000097:blood / Q000235:genetics / Q000627:therapeutic use
chemical_list: D007527:Isoenzymes; D011994:Recombinant Proteins; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D000519:alpha-Galactosidase